Perspective Therapeutics Inc CATX Q1 2026 Earnings Loss Narrows Sharply Stock Gains 284 CHH Q1 2026 Earnings EPS Misses Street Expectations as Shares Edge Higher SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise NUVB Q1 2026 Earnings Narrow EPS Beat Reflects Continued Pipeline Progress SPOK Q1 2026 Earnings EPS Misses Estimates by 51 Revenue Data Unavailable CLDX Q1 2026 Earnings Celldex Reports EPS Miss Amid EarlyStage Pipeline Progress CAKE Q1 2026 Earnings Modest EPS Beat Amidst Cautious Consumer Environment Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress ARKR Q4 2025 Earnings Loss Per Share of 059 as Restaurant Margins Remain Under Pressure MESO Q1 2026 Earnings Slightly Wider Loss in PreRevenue Quarter Stock Advances BrightView Holdings Inc Q1 2026 Earnings EPS Falls Short Amid Challenging Season LOCO Q1 2026 Earnings EPS Surges Past Estimates by 276 Shares Dip Slightly PHI Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Edges Higher